This study investigated the association between the expression of the CD47-SIRPα axis, clinicopathological characteristics, and survival in patients with ESCC who have undergone esophagectomy; assessed its prognostic significance; and evaluated its potential therapeutic value as a target for modulating the CD47-SIRPα pathway. This evidence concerns the gene CD47 and esophageal squamous cell carcinoma.